Randomized Phase-Ii Study With Gm-Csf And Low-Dose Arac In Patients With High-Risk Myelodysplastic Syndromes (Mds)Hh Gerhartz,R Marcus, A Delmer,H Zwierzina, T Dewitte,A Jacobs, G Visani, D Fiere,P Sonneveld,B Labar,Av Hoffbrand,P Fenaux,M Hayat,A Thyss, L Debucher,B Coiffier,W Sizoo,R Willemze,M Ribeiro, S Succiu,G Solbu,A Stern, R ZittounBREAKTHROUGH IN CYTOKINE THERAPY : AN OVERVIEW OF GM-CSF（1991）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
